Home > Income Statement > ALEMBIC PHARMACEUTICALS

ALEMBIC PHARMACEUTICALS
Revenue

    Back to Income Statement
ALEMBIC PHARMACEUTICALS is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for ALEMBIC PHARMACEUTICALS
Please provide your vote to see the results

ALEMBIC PHARMACEUTICALS Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹6,229 Cr₹5,653 Cr₹5,306 Cr₹5,393 Cr₹4,606 Cr

What is the latest Revenue of ALEMBIC PHARMACEUTICALS ?

The latest Revenue ratio of ALEMBIC PHARMACEUTICALS is ₹6,229 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹6,229 Cr
Mar2024₹5,653 Cr
Mar2023₹5,306 Cr
Mar2022₹5,393 Cr
Mar2021₹4,606 Cr

How is Revenue of ALEMBIC PHARMACEUTICALS Trending?

Years Revenue % Change
Mar2025 ₹6,229 Cr
10.19
Mar2024 ₹5,653 Cr
6.54
Mar2023 ₹5,306 Cr
-1.62
Mar2022 ₹5,393 Cr
17.10
Mar2021 ₹4,606 Cr -

Compare Revenue of peers of ALEMBIC PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ALEMBIC PHARMACEUTICALS ₹15,347.6 Cr 4.1% 2.3% -19% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹449,803.0 Cr 2.8% 1.8% 13.4% Stock Analytics
DIVIS LABORATORIES ₹179,219.0 Cr -0.2% -0.1% 3.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹152,417.0 Cr 1.4% -1.5% 39.9% Stock Analytics
CIPLA ₹116,116.0 Cr 6% 1.7% -4.4% Stock Analytics
DR REDDYS LABORATORIES ₹110,874.0 Cr 4.8% -0.3% -0.9% Stock Analytics


ALEMBIC PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
ALEMBIC PHARMACEUTICALS

4.1%

2.3%

-19%

SENSEX

-0.2%

2.1%

-5.6%


You may also like the below Video Courses